Menu
Colson Hicks Eidson has extensive experience representing victims in products liability actions who have suffered from taking prescription and over-the-counter drugs.
On April 7, 2005, the U.S. Food and Drug Administration (FDA) announced it had formally asked Pfizer, Inc. to voluntarily withdraw its COX-2 inhibitor Bextra, an anti-inflammatory painkiller linked to serious side effects. Pfizer agreed to the FDA’s request and pulled Bextra from the U.S. market.
Our Bextra lawsuit team has a long history of successful involvement in high profile product liability cases, including our work in Toyota unintended acceleration, Ford Pinto litigation and tire blowouts claims. For our efforts, many of our attorneys have been recognized as among the Best Lawyers in America and as Super Lawyers for product liability, medical malpractice, class actions, Our Miami drug injury attorneys remain committed to obtaining significant verdicts and settlements on behalf of patients harmed by COX-2 inhibitors and other dangerous drugs. As long as defective products continue to harm U.S. consumers, we will continue to fight for the compensation they deserve.
The FDA approved Bextra (valdecoxib) in 2001 to treat osteoarthritis, adult rheumatoid arthritis and menstrual-related pain. This drug has been linked to serious adverse side effects including:
Unfortunately for consumers, Bextra is not the only COX-2 inhibitor that has had to be recalled. Merck & Co. voluntarily withdrew its COX-2 inhibitor Vioxx in 2004 amidst growing concerns over the drug’s cardiovascular risks.
When a dangerous drug like Vioxx or Bextra harms patients, Colson Hicks Eidson fights to hold the manufacturers accountable. We have represented plaintiffs in Bextra lawsuits and will continue to protect consumers by filing individual claims and class action and multidistrict lawsuits against negligent pharmaceutical companies.
In 2009, Pfizer agreed to a $2.3 billion settlement to resolve allegations that it illegally marketed Bextra and other drugs for off-label purposes. Pfizer went so far as to publish a press release marketing Bextra as a morphine alternative following knee surgery, even though the FDA did not approve the drug to treat surgery-related pain.
In 2008, Pfizer agreed to set aside $894 million to resolve around 90 percent of the pending Bextra and Celebrex lawsuits that consumers had filed nationwide.
If you wish to pursue a claim against a pharmaceutical giant like Pfizer, our drug injury lawyers have the resources, experience and know-how to help you succeed.
If you or a loved one has suffered an injury from any prescription or over-the-counter drug, do not delay in seeking legal advice. Victims of dangerous drugs must file lawsuits before the statute of limitations expires, and these time limits vary from state to state. Colson Hicks Eidson represents clients nationwide and can determine the applicable statute of limitations in your case. Once it has expired, you may be forever barred from pursuing your claim.
To begin the process of seeking compensation for your drug-related injuries or the loss of your loved one, contact our drug injury attorneys at our Coral Gables FL office today. We offer free, no risk consultations and will gladly advise you of your legal rights. We assist victims nationwide, so if you or your loved one is a victim of harmful Bextra side effects or another dangerous drug, call 305-476-7400 today.
